Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Enrollment is no longer open to participants, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:40:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor backend/template update. No study details, eligibility criteria, or locations were changed.
    Difference
    0.1%
    Check dated 2026-06-05T13:11:16.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor site update.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:32.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s release rather than any study-specific information.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:44.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.0.0? to v3.5.2 on the page. This appears to be a minor maintenance update with no impact on content or functionality.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:55.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added the indexing term 'Mucopolysaccharidosis, MPS-II' and removed 'Mucopolysaccharidosis type 2' from the study's terminology list.
    Difference
    0.1%
    Check dated 2026-03-26T11:26:44.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.